Skip to main content

Table 3 Prevalence of somatic, psychological and urogenital symptoms and of anxiety/depression and OR (95% CI) for its association with menopausal status

From: How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

  Somatic symptoms Psychological symptoms Urogenital symptoms Anxiety/depression
  Crude Adjusteda   Crude Adjusteda   Crude Adjusteda   Crude Adjusteda
N (%) OR [95% CI] OR [95% CI] N (%) OR [95% CI] OR [95% CI] N (%) OR [95% CI] OR [95% CI] N (%) OR [95% CI] OR [95% CI]
Pre-menopause (N = 44) 15 (34.1%) 1 1 18 (40.9%) 1 1 19 (43.2%) 1 1 5 (11.4%) 1 1
Peri-menopause (N = 70) 42 (60.0%) 2.90 [1.37–6.16] 3.01 [1.38–6.55] 38 (54.3%) 1.72 [0.71–4.16] 2.18 [0.87–5.40] 34 (48.6%) 1.24 [0.65–2.4] 1.09 [0.57–2.09] 13 (18.6%) 1.78 [0.69–4.60] 2.33 [0.69–7.85]
Post-menopause (N = 137) 80 (58.4%) 2.71 [1.57–4.69] 2.63 [1.44–4.81] 83 (60.6%) 2.22 [1.21–4.06] 2.16 [1.13–4.14] 86 (62.8%) 2.22 [1.26–3.90] 2.54 [1.42–4.85] 30 (21.9%) 2.19 [0.88–5.41] 1.66 [0.48–5.67]
p value 0.011    0.072    0.030    0.300   
  1. Bold values are statistically significant
  2. OR: Odds Ratio from logistic regression for the association between menopausal status at the presence of menopausal symptoms in each MRS domain and of anxiety/depression
  3. aAdjusted for mode of transmission, current occupational status, smoking, drug use, social support, current partner